Chemotherapy Induced Peripheral Neuropathy (CIPN) is a chronic nerve condition caused by certain chemotherapy medications that damage peripheral nerves. Symptoms commonly include burning pain, numbness, tingling, hypersensitivity to temperature, weakness, and abnormal sensations in the hands, feet, or both.
CIPN may develop during chemotherapy treatment or even after treatment has ended. In many cases, symptoms become severe enough that patients consider stopping important cancer therapies due to the pain and discomfort associated with neuropathy.
Scrambler Therapy utilizes the FDA-cleared MC-5A device to deliver synthetic “non-pain” information through surface electrodes placed near affected areas. The treatment is designed to retrain how the brain interprets chronic neuropathic pain signals associated with chemotherapy-induced nerve damage.
Many patients experience meaningful reductions in burning pain, numbness, and abnormal sensations during a typical treatment cycle without invasive procedures or additional medications.
Researchers trained by Dr. Stephen J. D’Amato at Mayo Clinic and Johns Hopkins have independently demonstrated the benefits of Scrambler Therapy for Chemotherapy Induced Peripheral Neuropathy. Published research by physicians including Dr. Charles Loprinzi and Dr. Thomas Smith has further supported the treatment’s effectiveness.
Calmar Pain Relief has successfully treated many patients suffering from CIPN and remains one of the most experienced Scrambler Therapy providers in the United States.
If you believe you are a candidate for Scrambler Therapy, or you just want to learn more about this amazing technology or our practice, please reach out right away!
